Posted by admin on Jul 31st, 2022

Unicharm (OTCMKTS:UNICY – Get Rating) and DIAGNOS (OTCMKTS:DGNOF – Get Rating) are both consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, risk and dividends.

0.0% of Unicharm shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

This table compares Unicharm and DIAGNOS’s gross revenue, earnings per share and valuation.

Unicharm has higher revenue and earnings than DIAGNOS. DIAGNOS is trading at a lower price-to-earnings ratio than Unicharm, indicating that it is currently the more affordable of the two stocks.

This table compares Unicharm and DIAGNOS’s net margins, return on equity and return on assets.

Unicharm has a beta of 0.15, meaning that its share price is 85% less volatile than the S&P 500. Comparatively, DIAGNOS has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500.

This is a breakdown of recent recommendations and price targets for Unicharm and DIAGNOS, as reported by MarketBeat.

Unicharm beats DIAGNOS on 8 of the 10 factors compared between the two stocks.

Unicharm Corporation engages in the manufacture and sale of baby and childcare, feminine care, health care, cosmetic, household, and pet care products in Japan and internationally. Its baby and child care products, including disposable diapers, swimming and training pants, night time pants, nursing pads, wet tissues, and baby wipes under the Moony and MamyPoko brands; and feminine care products comprise napkins, tampons, pantiliners, underwear for periods, and other feminine care products under the Sofy, Center-In, and Unicharm brands. The company's health care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree brand. It also provides home care products, including cleaning sheets under the Wave brand; wet tissues and cosmetic puffs under the Silcot brand; and paper towels under the Cook Up brand. In addition, the company offers pet care products that include pet foods, excrement cleanup sheets, system toilets, and disposable diapers under the Aiken Genki, Neko Genki, Gaines, Gin no Spoon, and Gin no Sara brands; and masks; urinary products, such as gentle skin type and pantiliner type products, pants, napkins, men's incontinence pads, and slight leakage pads; and nursing care products that include tape type incontinence pad, pants type, and adult care products. Further, it is involved in the manufacture and sale of industrial materials, food-packaging materials, etc. The company was founded in 1961 and is headquartered in Tokyo, Japan.

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.

Receive News & Ratings for Unicharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unicharm and related companies with MarketBeat.com's FREE daily email newsletter.

Siltronic (FRA:WAF) Given a €90.00 Price Target by UBS Group Analysts

Endeavour Silver (NYSE:EXK) and Taseko Mines (NYSE:TGB) Critical Survey